Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2003
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149076 Administering drug formulation comprising opioidergic agent and an insulin secretagogue for therapy of human suffering from one or more conditions included within Coronary Heart Disease Risk Factor Syndrome
08/07/2003US20030149075 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003US20030149073 Cycloalkano-indole and -azaindole derivatives
08/07/2003US20030149071 Pyrido [2,1-a] isoquinoline derivatives
08/07/2003US20030149068 Use of chrysanthone A for the preparation of a medicament with antiangiogenic activity
08/07/2003US20030149058 Use of dipyridamole or mopidamol for treatment and prevention of fibrin-dependent microcirculation disorders
08/07/2003US20030149057 Anti-cancer compounds
08/07/2003US20030149051 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, cancer, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149046 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
08/07/2003US20030149044 Succinic acid salts of 5,7,14-triazatetracyclo[10.1.02.11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149040 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
08/07/2003US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient
08/07/2003US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149034 Indazoles substituted with1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
08/07/2003US20030149033 For prophylaxis and therapy of cerebrovascular diseases such as cerebral ischemia, stroke, reperfusion damage, brain trauma, edemas, cerebral thrombosis, dementia and Alzheimer's diseass
08/07/2003US20030149031 For therapy of inflammation
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149018 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/07/2003US20030149010 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
08/07/2003US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/07/2003US20030149003 Functionalized stilbene derivatives as improved vascular targeting agents
08/07/2003US20030149001 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/07/2003US20030148986 For therapy of atherosclerosis and other vascular diseases such as thrombosis, restenosis after angioplasty and/or stenting, and vein-graft disease after bypass surgery
08/07/2003US20030148962 For therapy of ischemic cerebral-vascular diseases
08/07/2003US20030148961 Peptidyl ketones as inhibitors of DPIV
08/07/2003US20030148960 For therapy and prophylaxis of congestive heart failure while avoiding or reducing aldosterone-antagonist-induced side effects such as hyperkalemia
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148946 Method and compositions for preventing hormone induced adverse effects
08/07/2003US20030148943 Novel tachykinin-like polypeptides and use thereof
08/07/2003US20030148941 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
08/07/2003US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders
08/07/2003US20030148923 Obtained by treating fish meat (sardine) with alkaline protease, then eluting peptide-adsorbing resin with ethanol; hypotensive agents; health food; for reducing blood pressure
08/07/2003US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents
08/07/2003US20030148513 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
08/07/2003US20030148512 Preparing culture of vascular system progenitor cells for tissue engineering and treatment of vascular disorders
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003US20030148398 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/07/2003US20030148327 Nucleic acid of given sequence; oligonucleotides and oligomers for detecting the cytosine methylation of genes; tumors and cancer
08/07/2003US20030148326 Diagnosis of diseases associated with dna transcription
08/07/2003US20030148323 Analyzing nucleic acid and determining presence of mutant alleles encoding a protein with reduced activity/thermal stability; useful in diagnosing schizophrenia
08/07/2003US20030148099 Microcapsules having high carotenoid content
08/07/2003US20030147945 Vehicles stably associated with non-antagonistic combinations of >/= 2 synergistic agents
08/07/2003US20030147942 Pharmaceutical gel composition
08/07/2003US20030147937 Di-myo-inositol phosphate, cyclic 2,3 diphosphoglycerate, 1,1-di- glycerol phosphate, mannosylglycerate, mannosyl glyceramide and/or di-mannosyl-di-inositol phosphate; protecting organisms, organs, tissues, cells from oxidation
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147862 Administering a colony stimulating factor and/or a nucleic acids encoding the factor; treating a vascular tumor
08/07/2003US20030147815 Administering tri-(or tetra-)iodothyropropionic acid
08/07/2003CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003CA2475003A1 Double-stranded oligonucleotides
08/07/2003CA2474910A1 Oligonucleotide compositions with enhanced efficiency
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474852A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003CA2474845A1 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of pathogenic conditions
08/07/2003CA2474788A1 Compositions and methods for modulating connexin hemichannels
08/07/2003CA2474759A1 Gene for peripheral arterial occlusive disease
08/07/2003CA2474702A1 Heterocyclic arylsulfonamidobenzylic compounds
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474447A1 Pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474433A1 Arylsulfonamidobenzylic compounds
08/07/2003CA2474414A1 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003CA2474316A1 Kappa-pviia-related conotoxins as organ protectants
08/07/2003CA2473810A1 Fgfr agonists
08/07/2003CA2473797A1 Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
08/07/2003CA2473249A1 New corticosteroids
08/07/2003CA2473169A1 Compounds that inhibit factor xa activity
08/07/2003CA2473164A1 Novel compounds that inhibit factor xa activity
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003CA2473128A1 Genetic polymorphisms in the preprotachykinin gene
08/07/2003CA2472342A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003CA2471850A1 A method and system for treating an atrial arrhythmia
08/07/2003CA2466915A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003CA2443023A1 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/06/2003EP1333026A1 Process for the preparation of high purity perindopril and intermediates useful in the synthesis
08/06/2003EP1332761A1 Agonists of fibroblast growth factor receptors (FGFR)
08/06/2003EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
08/06/2003EP1332151A1 Pyranoside derivatives
08/06/2003EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
08/06/2003EP1332147A1 Thieno[2,3-c isoquinolines for use as inhibitors of parp
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332144A1 Indole derivatives as pde5-inhibitors
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332130A2 Atorvastatin hemi-calcium form vii
08/06/2003EP1332128A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1331938A1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
08/06/2003EP1331935A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
08/06/2003EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators
08/06/2003EP1189929B1 Factor viia inhibitors
08/06/2003EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
1 ... 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 ... 1595